FDA's NDI Guidance: What You Need to Know

FDA’s NDI Guidance: What You Need to Know

Presented: July 19, 2011

Published: Tuesday, July 19, 2011

The FDA released the draft New Dietary Ingedient (NDI) guidance on July 5, 2011. AHPA's educational seminar, featuring presentations from AHPA President Michael McGuffin, General Counsel Tony Young, former FDA insider Bill Frankos, Ph.D., and a panel of legal experts with experience filing over 30 NDI notifications, assists with understanding the key elements of the guidance and how it will impact businesses in the supplement industry. Discussion topics include historical background, FDA's rationale during the development of the guidance, general business impact, GRAS status and NDI, and the potential impact to specific categories such as probiotics, nanotechnology, and others.

Take advantage of the expertise of these speakers:
  • Jim Prochnow, Esq, Greenberg Traurig
  • Tony Young, Esq, Kleinfeld, Kaplan & Becker
  • Ashish Talati, Esq, Amin Talati
  • Paul Rubin, Esq, Patton Boggs
  • Alan Feldstein, Esq, Collins, McDonald & Gann
  • Michael McGuffin, AHPA
Materials in this packet include:
  • Presentation files from the webinar
  • Audio file
Member Price: $220.00
Non-Member Price: $520.00


2021 Annual Fund Sponsors


AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.